TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Rate of composite endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Subjects with Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Survival predictive accuracy
Endpoint domain: Mortality/survival
Primary endpoint: modified Medical Research Council (mMRC) score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Expression levels of cell markers on blood eosinophils
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Fear of cancer recurrences scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence and severity of device-related and procedure-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Presence and nature of psychiatric disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved Harris hip score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PRO rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cartilage damage outerbridge grading
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to PSA progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Time to Radiographic progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Knowledge Scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Help-seeking Intentions Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Degree of incision closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Behavior Rating Inventory of Executive Function-Preschool Version (BRIEF-P)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: NIH Toolbox Early Childhood Cognitive Battery
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: EEG-Based indices of EF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in urinary oxalate to creatinine ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Absolute change in urinary oxalate to creatinine ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean change in frequency of moderate to severe hot flashes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak expiratory flow rate (PEFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Care Dependency Level
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: acute transfusion reaction (CTCAE ≥ 2)
Endpoint domain: Adverse events/effects
Primary endpoint: acute GvHD grade II-IV
Endpoint domain: Adverse events/effects
Primary endpoint: acceptance of dental treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in proximal contact tightness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall experience with the robot for the family
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall experience with the robot for the resident
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ease of use of the robot for the family
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ease of use of the robot for the resident
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: home literacy scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: parental stress levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: parent-infant bonding scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mean total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Presence of renal allograft fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Spinal Cord Injury Functional Inventory basic mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spinal Cord Injury Functional Inventory motorized wheelchair mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spinal Cord Injury Functional Inventory resilience
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes in migraine frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 50% Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Active zone minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ambulatory Diastolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in Opioid Consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Side Effect Profiles of Topiramate
Endpoint domain: Adverse events/effects
Primary endpoint: Side Effect Profiles of gabapentin
Endpoint domain: Adverse events/effects
Primary endpoint: tartrate resistant acid phosphatase-5b (TRACP-5b)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Related Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Bleeding on probing index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Follicle-stimulating Hormone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Right Atrial Autothreshold values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Right Ventricular pacing threshold values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Technical remote alerts
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percent change in DXA-obtained muscle mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in DXA-obtained fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in bodyweight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability - assessed by the SUS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients with significant symptom reduction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Overall wearing comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline in static balance on Diasu Gait Analysis Device at Week 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in weight bearing on Diasu Gait Analysis Device at Week 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in quality of life and functionality on Nottingham Health Profile at Week 8
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Safety and tolerability of AND017
Endpoint domain: Adverse events/effects
Primary endpoint: C. difficile infection recurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients with LDL measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patients with HbA1c measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Characterization of fecal microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of hypotension during surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in Periorbital Wrinkles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Premature Ovarian Failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Monocyte chemotaxis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Monocyte derived foam cell formation of monocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: MR Elimination at 1 Year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lens removal time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Safety of DEC-C in combination with Nivolumab
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Completing Intervention Sessions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Diabetes control as reported hemoglobin A1c levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reported Low-density lipoprotein (LDL)/High-density lipoprotein (HDL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Perception of Conversation Index - Dementia Alzheimer's Type (PCI-DAT)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Muscle oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence, duration, and severity of solicited local and systemic AEs for 7 days following vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence, severity, and relationship of unsolicited AEs through 28 days after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence and severity of MAAEs attributed to study vaccine and serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Neutralizing antibody (NAb) expressed as geometric mean titers (GMTs) to the Omicron XBB.1.5 strain
Endpoint domain: Physiological/clinical
Primary endpoint: Neutralizing antibody (NAb) expressed as geometric mean fold rise (GMFR) to the Omicron XBB.1.5 strain
Endpoint domain: Physiological/clinical
Primary endpoint: Manual Muscle Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: The Lower Extremity Functional Scale (LEFS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sleeping quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Sleeping disorders
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Self-reported receipt of COVID vaccine dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects remaining out of the hospital or emergency room
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: ARFI PD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VisR Tau
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VisR RE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of Palliative Care Visit
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence and severity of AESIs
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in Kidney Therapy Decision-Making Process
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Uptake of HIV counseling and testing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: percent increase in fat-free mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Radiation-free survival (RFS)
Endpoint domain: Mortality/survival
Primary endpoint: Number of participants with ocular and overall adverse events (AEs) and serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in SD-OCT measures and appearance of retinal layers over-time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response Assessment in Study Participants With PV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in physical activity outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in diet behavioral outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in adiposity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in blood pressure readings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in fasting glucose values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in T-regulatory cells in tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in CD8+ T cells in tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in myeloid cells in tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Grey level co-occurrence matrix texture features
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle strength assessment of the hip
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Muscle strength assessment of the knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: One Leg Standing Test (eyes open and closed)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Half Squat Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Curl-Up Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body Awareness Questionnaire (BAQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: effective communication skills
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of all-cause mortality, stroke, TIA, and Acute Kidney Injury Stage 2 or 3
Endpoint domain: Mortality/survival
Primary endpoint: Debris capture (average number of captured particles ≥150 µm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Drug Related Readmissions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Safety and tolerability of CAP256J3LS
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in Post-exercise Left Ventricular Outflow Tract (LVOT) Peak Gradient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Occurrence of late PTS
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of PTS
Endpoint domain: Adverse events/effects
Primary endpoint: survival after 8, 16, and 24 weeks
Endpoint domain: Mortality/survival
Primary endpoint: oesophageal motility changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: rectus abdominis cross section area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: intra-recti distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Concentration of phosphatidylcholine in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of Participants Achieving HiSCR75
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TNF ALPHA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Safety and tolerability of eOD-GT8 60mer mRNA Vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Change in pulse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean change in score of visual analog scale to assess potential for misuse of MDMA
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Level of agreement in decision for toxin treatment referral
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: prevalence of coronal caries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: prevalence of radicular caries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Employee Voice Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Visual Correction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vessel-level delta FFRangio values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in PROMIS global
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Changes in food frequency questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Nutritional outcomes
Primary endpoint: Absence of active ROP and unfavorable structural outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmic outcomes
Primary endpoint: Skeletal muscle index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Population-level TB prevalence
Endpoint domain: Mortality/survival
Primary endpoint: Progression of adenomyosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Abundance of fructose in tumor extracts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Functional Vision Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Serum IRAP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Maximum load, one repetition maximum, leg press
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difficulties in emotion regulation scale (DERS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Five facet mindfulness questionnaire (FFMQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-compassion scale long form (SCS-LF)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: International trauma questionnaire (ITQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Intracranial tumor progression-free survival (iPFS)
Endpoint domain: Mortality/survival
Primary endpoint: Activity of electrochemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Active Tuberculosis Cases per 1000 Patient-years
Endpoint domain: Adverse events/effects
Primary endpoint: Cost of any additional diagnostic tests done by a participant
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cost of any additional consults done by a participant
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total cost of any antimicrobial treatments by a participant
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of participants that were admitted to the hospital
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Cost of hospital stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Variability of hypoxia in HCC quantified by BOLD MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variability of hypoxia in HCC quantified by immunohistochemistry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of finishing the study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Feasibility of home based stimulation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility of network targeting
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: tumor assessment timepoints
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Inspiratory Transpulmonary Pressure (Ptpins)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Maxillary sinus and pharyngeal airway morphometric dimension changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The range of motion of the ankle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The measurement of swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunogenicity of Third Dose Vaccine Booster
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reactogenicity of Third Dose Vaccine Booster
Endpoint domain: Adverse events/effects
Primary endpoint: Therapist acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Study adherence of participants
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Experienced acceptability and burden
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Diuretic efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Follicle Stimulating Hormone (FSH) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Body height measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes